| Literature DB >> 32432817 |
Aggie Lawer1, Ryan G Epton1, Thomas C Stephens1, Kleopas Y Palate1, Mahendar Lodi1, Emilie Marotte2, Katie J Lamb1, Jade K Sangha1, Jason M Lynam1, William P Unsworth1.
Abstract
The outcome of ring-expansion reactions based on amino/hydroxyacid side-chain insertion is strongly dependent on ring size. This manuscript, which builds upon our previous work on Successive Ring Expansion (SuRE) methods, details efforts to better define the scope and limitations of these reactions on lactam and β-ketoester ring systems with respect to ring size and additional functionality. The synthetic results provide clear guidelines as to which substrate classes are more likely to be successful and are supported by computational results, using a density functional theory (DFT) approach. Calculating the relative Gibbs free energies of the three isomeric species that are formed reversibly during ring expansion enables the viability of new synthetic reactions to be correctly predicted in most cases. The new synthetic and computational results are expected to support the design of new lactam- and β-ketoester-based ring-expansion reactions.Entities:
Keywords: density functional theory; macrocycles; rearrangement; ring expansion; ring systems
Mesh:
Substances:
Year: 2020 PMID: 32432817 PMCID: PMC7589337 DOI: 10.1002/chem.202002164
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236
Scheme 1Side‐chain insertion ring‐expansion reactions and Successive Ring Expansion (SuRE).
Scheme 2Ring‐size dependency on the outcome of the ring expansion of imides into aza‐lactones. Δ values are given in kcal mol−1.
Scheme 3Ring‐size dependency on the outcome of the ring expansion of imides with N‐methyl sarcosine derivatives. Δ values are given in kcal mol−1 with thermal corrections at 298 K.
Scheme 4Scope of lactam ring‐expansion reactions with N‐functionalised amino acids.
Scheme 5Ring‐size dependency of the outcome of the ring expansion of β‐ketoesters with β‐alanine‐derived acid chloride 29. Δ values are given in kcal mol−1.
Scheme 6Ring‐size dependency of the outcome of the ring expansion of β‐ketoesters with β‐hydroxy acid chloride 38. Δ values are given in kcal mol−1. i) β‐ketoester, 38, MgCl2, pyridine, CH2Cl2, RT; ii) Pd/C H2, EtOAc, 3 h, RT; NEt3, CHCl3, RT, 18 h.
Scheme 7Lactam ring‐expansion reactions and DFT calculations. Δ values are given in kcal mol−1.
Figure 1Successive ring expansion products.
Relative difference of Gibbs energies at 298 K for structures 17–20 at different levels of theory. Solvent corrections were applied using a PCM model. * Geometry from the BP86/SV(P) level.
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
|
Compound |
Functional |
Basis set |
Solvent correction |
Empirical dispersion correction |
RO [kcal mol−1] |
RC [kcal mol−1] |
RE [kcal mol−1] |
Yield RE [%] |
|
|
B3LYP |
6‐31G* |
N |
N |
0.0 |
16.5 |
1.9 |
0 |
|
B3LYP |
6‐31G* |
PCM |
N |
0.0 |
14.9 |
0.2 | ||
|
BP86 |
6‐31G* |
N |
N |
0.0 |
14.9 |
1.6 | ||
|
PBE0 |
6‐31G* |
N |
N |
0.0 |
14.1 |
1.2 | ||
|
M06 |
6‐31G* |
PCM |
N |
0.0 |
10.8 |
−2.1 | ||
|
M06‐2X |
6‐31G* |
PCM |
N |
0.0 |
8.7 |
−1.6 | ||
|
BP86 |
SV(P) |
PCM |
N |
0.0 |
11.5 |
−2.1 | ||
|
PBE0* |
def2‐TZVPP |
PCM |
D3(BJ) |
0.0 |
9.2 |
−3.3 | ||
|
|
|
|
|
|
|
|
|
|
|
|
B3LYP |
6‐31G* |
N |
N |
0.0 |
3.9 |
2.1 |
0 |
|
B3LYP |
6‐31G* |
PCM |
N |
0.0 |
2.2 |
−1.1 | ||
|
BP86 |
6‐31G* |
N |
N |
0.0 |
0.5 |
−1.1 | ||
|
PBE0 |
6‐31G* |
N |
N |
0.0 |
−0.6 |
−1.6 | ||
|
M06 |
6‐31G* |
PCM |
N |
0.0 |
−3.0 |
−3.8 | ||
|
M06‐2X |
6‐31G* |
PCM |
N |
0.0 |
−4.5 |
−4.1 | ||
|
BP86 |
SV(P) |
PCM |
N |
0.0 |
−1.2 |
−3.0 | ||
|
PBE0* |
def2‐TZVPP |
PCM |
D3(BJ) |
0.0 |
−3.0 |
−5.3 | ||
|
|
|
|
|
|
|
|
|
|
|
|
B3LYP |
6‐31G* |
N |
N |
0.0 |
6.4 |
0.7 |
0 |
|
B3LYP |
6‐31G* |
PCM |
N |
0.0 |
6.2 |
−0.3 | ||
|
BP86 |
6‐31G* |
N |
N |
0.0 |
5.5 |
−0.4 | ||
|
PBE0 |
6‐31G* |
N |
N |
0.0 |
4.4 |
−1.3 | ||
|
M06 |
6‐31G* |
PCM |
N |
0.0 |
1.1 |
−3.8 | ||
|
M06‐2X |
6‐31G* |
PCM |
N |
0.0 |
−0.5 |
−3.4 | ||
|
BP86 |
SV(P) |
PCM |
N |
0.0 |
2.7 |
−1.8 | ||
|
PBE0* |
def2‐TZVPP |
PCM |
D3(BJ) |
0.0 |
0.7 |
−5.0 | ||
|
|
|
|
|
|
|
|
|
|
|
|
B3LYP |
6‐31G* |
N |
N |
7.3 |
14.1 |
0.0 |
82 |
|
B3LYP |
6‐31G* |
PCM |
N |
9.9 |
16.1 |
0.0 | ||
|
BP86 |
6‐31G* |
N |
N |
8.3 |
13.8 |
0.0 | ||
|
PBE0 |
6‐31G* |
N |
N |
8.8 |
13.3 |
0.0 | ||
|
M06 |
6‐31G* |
PCM |
N |
12.2 |
12.8 |
0.0 | ||
|
M06‐2X |
6‐31G* |
PCM |
N |
11.4 |
10.5 |
0.0 | ||
|
BP86 |
SV(P) |
PCM |
N |
11.1 |
13.6 |
0.0 | ||
|
PBE0* |
def2‐TZVPP |
PCM |
D3(BJ) |
13.4 |
14.0 |
0.0 | ||
Relative difference of Gibbs energies at 298 K. Solvent corrections were applied using a PCM model with either dichloromethane or chloroform as relevant for the M06‐2X/6‐31G* calculations. See the Supporting Information for absolute energies. Blue numbers denotes the most significant differences between the two methods >3 kcal mol−1. Δave is defined as the mean value of the energy at M06‐2X/6‐31G*—energy at B3LYP/6‐31G*.
|
Compound |
Functional/ |
RO |
RC |
RE |
Yield |
|---|---|---|---|---|---|
|
|
basis set |
[kcal mol−1] |
[kcal mol−1] |
[kcal mol−1] |
RE [%] |
|
|
B3LYP/6‐31G* |
10.0 |
12.6 |
0.0 |
67 |
|
M06‐2X/6‐31G* |
12.5 |
10.2 |
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
8.1 |
9.7 |
0.0 |
82 |
|
M06‐2X/6‐31G* |
10.5 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
36.6 |
45.4 |
0.0 |
80 |
|
M06‐2X/6‐31G* |
38.0 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
9.3 |
11.8 |
0.0 |
59 |
|
M06‐2X/6‐31G* |
11.7 |
8.1 |
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
10.8 |
10.3 |
0.0 |
56 |
|
M06‐2X/6‐31G* |
10.3 |
3.7 |
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
35.2 |
39.8 |
0.0 |
– |
|
M06‐2X/6‐31G* |
32.6 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
0.0 |
9.7 |
0.0 |
41 |
|
M06‐2X/6‐31G* |
|
7.1 |
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
2.9 |
9.2 |
0.0 |
67[a] |
|
M06‐2X/6‐31G* |
5.0 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
5.5 |
17.9 |
0.0 |
70 |
|
M06‐2X/6‐31G* |
11.7 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
10.4 |
19.6 |
0.0 |
75 |
|
M06‐2X/6‐31G* |
11.2 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
6.7 |
18.4 |
0.0 |
99 |
|
M06‐2X/6‐31G* |
12.0 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
10.9 |
20.3 |
0.0 |
73 |
|
M06‐2X/6‐31G* |
14.5 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
−2.5 |
13.4 |
0.0 |
40 |
|
M06‐2X/6‐31G* |
|
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
−3.3 |
10.6 |
0.0 |
0 |
|
M06‐2X/6‐31G* |
|
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
5.9 |
24.2 |
0.0 |
77 |
|
M06‐2X/6‐31G* |
9.4 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
3.9 |
17.7 |
0.0 |
71 |
|
M06‐2X/6‐31G* |
6.0 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
|
|
0.0 |
30 |
|
M06‐2X/6‐31G* |
9.2 |
5.7 |
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
3.5 |
19.6 |
0.0 |
84 |
|
M06‐2X/6‐31G* |
9.8 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
B3LYP/6‐31G* |
4.8 |
14.5 |
0.0 |
45 |
|
M06‐2X/6‐31G* |
6.6 |
|
0.0 | ||
|
|
|
|
|
|
|
|
|
Δave |
3.1 |
|
0.0 |
[a] Isolated as a mixture (54/54 4:3).